V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002409 | 210008304 | 1.63 | 60 | Adjuvant (A) | 2017-03-29 | 2017-05-11 | Trastuzumab | 02 | N | TRASTUZUMAB | 100336771 |
| 210002413 | 210008306 | null | null | Adjuvant (A) | 2016-06-28 | 2016-10-12 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101324725 |
| 210002416 | 210008307 | 1.63 | null | Neo-adjuvant (N) | null | 2018-12-30 | Trastuzumab | 02 | N | TRASTUZUMAB | 101057912 |
| 210002418 | 210008309 | 1.47 | 72.4 | null | 2019-08-13 | 2019-11-12 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101805602 |
| 210002419 | 210008310 | 1.63 | null | Neo-adjuvant (N) | 2018-11-06 | 2019-02-20 | Paclitaxel 7 day | N | N | PACLITAXEL | 100242700 |
| 210002420 | 210008311 | null | 68 | null | 2016-10-18 | 2017-01-29 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101655033 |
| 210002421 | 210008312 | 1.65 | 72.5 | Palliative (P) | 2018-06-24 | 2018-10-23 | Trastuzumab | null | null | TRASTUZUMAB | 100538890 |
| 210002422 | 210008313 | 1.48 | 77.8 | null | 2019-05-29 | 2019-07-03 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101383144 |
| 210002423 | 210008314 | 1.52 | 67.7 | Adjuvant (A) | 2020-11-08 | 2020-12-19 | Docetaxel | 02 | N | DOCETAXEL | 100410783 |
| 210002426 | 210008315 | 1.57 | 92.2 | Adjuvant (A) | 2018-03-28 | 2018-04-04 | Docetaxel | 02 | N | DOCETAXEL | 101417041 |
| 210002427 | 210008316 | null | null | null | 2018-08-07 | 2018-08-10 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101531006 |
| 210002428 | 210008317 | 1.63 | 70.1 | Palliative (P) | 2020-01-11 | 2020-03-22 | Trastuzumab | 02 | null | TRASTUZUMAB | 101140143 |
| 210002432 | 210008319 | 1.58 | 69.6 | null | null | 2020-03-03 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 101549675 |
| 210002433 | 210008320 | null | null | Neo-adjuvant (N) | 2016-05-18 | 2017-12-01 | Docetaxel | 02 | null | DOCETAXEL | 100096208 |
| 210002434 | 210008321 | 1.59 | null | Adjuvant (A) | 2016-09-04 | 2017-02-10 | Docetaxel | 02 | N | DOCETAXEL | 100377031 |
| 210002435 | 210008322 | 1.52 | 81.2 | Palliative (P) | null | 2019-09-04 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100387725 |
| 210002441 | 210008324 | 1.75 | 68 | Adjuvant (A) | 2017-02-11 | 2017-03-01 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100246549 |
| 210002443 | 210008325 | 1.64 | 82.2 | null | 2020-11-10 | 2020-11-18 | Docetaxel | 02 | Y | DOCETAXEL | 101261577 |
| 210002445 | 210008326 | 1.71 | 88.8 | Neo-adjuvant (N) | null | 2022-05-25 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100482271 |
| 210002447 | 210008327 | 1.64 | 72.3 | Adjuvant (A) | null | 2021-05-21 | Docetaxel | null | N | DOCETAXEL | 100523914 |
| 210002448 | 210008328 | 1.59 | 76 | Adjuvant (A) | 2020-08-14 | 2020-10-24 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100107743 |
| 210002450 | 210008330 | 1.59 | 87.1 | Adjuvant (A) | 2019-03-15 | 2019-04-10 | PACLITAXEL | null | N | PACLITAXEL | 100989136 |
| 210002452 | 210008331 | 0 | 66.2 | Adjuvant (A) | null | 2019-12-16 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | PACLITAXEL | 101312703 |
| 210002454 | 210008332 | 1.79 | 69.9 | Adjuvant (A) | 2020-04-30 | 2020-05-02 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100103923 |
| 210002455 | 210008333 | null | 49.6 | Adjuvant (A) | 2019-07-12 | 2019-10-10 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100766845 |
| 210002456 | 210008334 | 1.59 | 98.9 | Palliative (P) | 2017-06-01 | 2017-08-18 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101297976 |
| 210002458 | 210008335 | 1.72 | 55 | Adjuvant (A) | null | 2017-04-24 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100000984 |
| 210002459 | 210008336 | 1.73 | 82 | Neo-adjuvant (N) | 2020-09-22 | 2020-10-06 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 100055273 |
| 210002462 | 210008338 | 1.58 | 61.7 | Adjuvant (A) | null | 2019-08-14 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100893409 |
| 210002463 | 210008339 | null | 56.7 | Disease modification (D) | 2020-07-30 | 2020-10-22 | Docetaxel | 02 | N | DOCETAXEL | 100095733 |
| 210002465 | 210008341 | 1.6 | 65.4 | Adjuvant (A) | 2020-03-11 | 2020-04-09 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101080966 |
| 210002467 | 210008343 | 1.61 | 58.5 | Neo-adjuvant (N) | 2018-02-10 | 2018-05-02 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100194392 |
| 210002471 | 210008345 | 1.63 | 105 | Adjuvant (A) | 2021-10-25 | 2021-11-06 | Docetaxel | 02 | N | DOCETAXEL | 101529186 |
| 210002472 | 210008346 | 1.65 | 73.7 | Adjuvant (A) | null | 2018-12-02 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100835878 |
| 210002474 | 210008347 | 1.63 | 102.5 | Adjuvant (A) | null | 2022-03-09 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101559598 |
| 210002477 | 210008349 | 0 | 69 | Adjuvant (A) | 2020-03-02 | 2020-03-14 | PACLITAXEL | 02 | N | PACLITAXEL | 100752839 |
| 210002478 | 210008350 | 1.73 | 88.8 | Adjuvant (A) | 2018-11-16 | 2018-11-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100422057 |
| 210002483 | 210008351 | 1.68 | 64 | Adjuvant (A) | 2017-12-19 | 2018-05-30 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100752618 |
| 210002488 | 210008353 | 1.62 | 63.4 | Palliative (P) | null | 2019-08-05 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100240091 |
| 210002491 | 210008354 | 1.58 | 86.2 | Adjuvant (A) | null | 2016-10-24 | Trastuzumab | 02 | N | TRASTUZUMAB | 100515589 |
| 210002492 | 210008355 | 1.5 | null | Adjuvant (A) | 2021-01-09 | 2021-04-19 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100166502 |
| 210002495 | 210008356 | 1.53 | 80.4 | Adjuvant (A) | 2017-11-09 | 2018-02-15 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100750600 |
| 210002496 | 210008357 | 1.66 | 87.7 | Palliative (P) | null | 2016-11-26 | Trastuzumab | 02 | null | TRASTUZUMAB | 101241030 |
| 210002499 | 210008358 | null | 45.2 | null | 2017-01-16 | 2017-04-20 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100841492 |
| 210002501 | 210008360 | null | null | Adjuvant (A) | null | 2020-02-12 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100816955 |
| 210002504 | 210008363 | 1.52 | 65 | Adjuvant (A) | null | 2016-07-29 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100581163 |
| 210002505 | 210008364 | 1.67 | 62.8 | Neo-adjuvant (N) | null | 2018-12-13 | Trastuzumab | 02 | N | TRASTUZUMAB | 101265246 |
| 210002506 | 210008365 | 1.53 | 92 | null | 2019-11-22 | 2020-02-10 | Paclitaxel 7 day | null | N | PACLITAXEL | 101345386 |
| 210002508 | 210008366 | 1.69 | 92 | null | 2018-07-23 | 2018-10-20 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101078679 |
| 210002509 | 210008367 | 1.54 | 66 | Adjuvant (A) | null | 2021-01-10 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101248333 |